Drug intelligence / Profile preview

royal jelly

Development stage
Unknown
Modality
Peptides, Small Molecules, Recombinant Proteins and Enzymes
Administration
Oral, Topical
01

Overview

Royal jelly is a complex honey bee secretion produced by the hypopharyngeal and mandibular glands of worker bees, primarily used for the nutrition of larvae and queen bees. It is composed of water, proteins (notably Major Royal Jelly Proteins or MRJPs), sugars, lipids (such as 10-hydroxy-2-decenoic acid), vitamins, and minerals. In clinical research, royal jelly is investigated for its potent anti-inflammatory, immunomodulatory, and antioxidant properties. It has been shown to modulate the production of pro-inflammatory cytokines like TNF-α, IL-6, and IL-17, and growth factors such as TGF-β and M-CSF. In oncology, royal jelly is studied as a complementary therapy to reduce adverse effects of chemotherapy and molecular targeted therapies, such as fatigue and anorexia, and for its potential direct anti-tumor effects mediated through the inhibition of STAT3 signaling and VEGF-induced angiogenesis.

Brand names
Royal Jelly capsules
Other names
RJ
02

Targets

CSF1R (Macrophage colony-stimulating factor receptor)IL-6 (Interleukin 6)VEGFA (Vascular endothelial growth factor A)TGFB1 (Transforming growth factor Beta-1 proprotein)TP53 (Cellular Tumor Antigen p53 R175H)TNFA (Tumor necrosis factor alpha (soluble))STAT3 (Signal Transducer and Activator of Transcription 3)IL-17A (Interleukin-17A)

Beyond the preview

Go deeper on royal jelly.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on royal jelly.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call